NEW YORK, Nov. 18, 2014 /PRNewswire/ -- As Risperdal lawsuits (http://www.risperdallawsuit2014.com/) move forward in U.S. courts, Bernstein Liebhard LLP notes that the use of antipsychotic drugs has risen significantly among children in Australia. According to a report from the U.K.'s Daily Mail, more than 100,000 antipsychotic prescriptions were written for Australian children in 2013. Risperidone (sold in the U.S. under the brand name Risperdal) Quetiapine and Olanzapine were the three most commonly prescribed medicines. The report noted that the number of prescriptions greatly outpaced the number of Australian children who suffer from bipolar disorder, schizophrenia and other psychotic ailments, suggesting that many were receiving the medications off-label for unapproved indications.
"Hundreds of people in the U.S. are now pursuing Risperdal lawsuits for gynecomastia, or male breast growth, and other complications allegedly associated with its use. In noting that Risperdal and other antipsychotic medications should be used cautiously, this report points to many of these same complications," says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia due to their use of Risperdal.